| abstract |
The present invention relates to the use of CBP / EP300 bromodomain inhibitors for the treatment of cancer. In one aspect, a method is provided for treating or slowing the progression of cancer in an individual comprising administering to the individual an effective amount of a CBP / EP300 bromodomain inhibitor. In another aspect, a method is provided for enhancing immune function in an individual having cancer, comprising administering to the individual an effective amount of a CBP / EP300 bromodomain inhibitor. |